Quanterix Agrees to Buy Life Sciences Firm Akoya Biosciences
Quanterix Corp. agreed to acquire life sciences peer Akoya Biosciences Inc. in an all-stock deal, combining two companies ...
The American Journal of Managed Care23h
Elinzanetant Excels in Phase 3 Study for Vasomotor Symptom Relief
Trial confirms elinzanetant's efficacy and safety in addressing vasomotor symptoms caused by adjuvant endocrine therapy in ...
Why biotech startup Tenvie sees promise in drugs from founders' old company
About a year ago, Tenvie President and Chief Scientific Officer Tony Estrada approached Denali CEO Ryan Watts and others in ...
Genenta Strengthens Agreement with AGC Biologics to Boost Cell Therapy Manufacturing
The newly approved methastatic Renal Cell Cancer (mRCC) Phase 1/2a trial began in Q4 2024, and Genenta expects to treat six patients by the end of the first half of 2025, while continuing progress ...
BioPharma Dive2d
Tenvie raises $200M for brain drug R&D; Sana spikes on single patient’s results
The Arch-backed startup begins life with several assets acquired from Denali Therapeutics. Elsewhere, Jasper got a negative ...
technologynetworks3d
Important Factors to Consider When Designing Your RNA-Seq Experiment
Designing an RNA-Seq experiment is a multi-faceted process that requires careful planning and execution. From selecting the right assay to optimizing library preparation, every decision impacts the ...
technologynetworks4d
A Biopharmaceutical Company’s Journey to Savings and Optimized Sample Management
Learn how this client partnered with Azenta Life Sciences to integrate industry-leading sample capabilities and ...